U.S. markets close in 1 hour 45 minutes

ERYTECH Pharma S.A. (ERYP.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
4.2850-0.0150 (-0.35%)
At close: 5:35PM CEST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in EUR

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/15/2021
Current
3/31/202112/31/20209/30/2020
Market Cap (intraday) 5
112.00M130.57M142.59M97.81M
Enterprise Value 3
94.99M113.56M113.61M68.83M
Trailing P/E
N/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/A
Price/Book (mrq)
4.224.922.791.91
Enterprise Value/Revenue 3
N/AN/AN/AN/A
Enterprise Value/EBITDA 7
-1.44-10.14-5.62-4.25

Trading Information

Stock Price History

Beta (5Y Monthly) 1.87
52-Week Change 3-52.75%
S&P500 52-Week Change 336.18%
52 Week High 310.4400
52 Week Low 34.1650
50-Day Moving Average 35.1532
200-Day Moving Average 36.7610

Share Statistics

Avg Vol (3 month) 3124.91k
Avg Vol (10 day) 3170.74k
Shares Outstanding 526.05M
Implied Shares Outstanding 6N/A
Float 14.95M
% Held by Insiders 11.75%
% Held by Institutions 138.59%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Mar 31, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,427.93%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.41M
Revenue Per Share (ttm)0.22
Quarterly Revenue Growth (yoy)92.80%
Gross Profit (ttm)3.72M
EBITDA -59.11M
Net Income Avi to Common (ttm)-67.66M
Diluted EPS (ttm)-3.3770
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.45M
Total Cash Per Share (mrq)2.22
Total Debt (mrq)27.45M
Total Debt/Equity (mrq)103.43
Current Ratio (mrq)N/A
Book Value Per Share (mrq)1.32

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A